In-Person Care in Walnut Creek | Virtual Care Available

Aberrant Cell Growth Module | Early Cancer Risk Detection & Prevention in Walnut Creek, CA

Aberrant Cell Growth Module

Aberrant-Cell-Growth-Medical-Institute-of-Healthy-Aging-800-x-900-px-.png

Detect What Others Don’t See — Before It Becomes a Problem

Cancer remains one of the leading causes of death worldwide, and yet many traditional screenings fail to detect early, subtle changes that can signal future risk. That’s where MIHA’s Aberrant Cell Growth Module stands apart.

This program uses advanced screening technologies and biomarker testing to look for early signs of abnormal cell activity — long before it becomes a diagnosable disease. Our goal isn’t to wait and react — it’s to intervene earlier, more precisely, and more effectively.

Schedule Your Appointment

Why Early Detection Matters

In the 1970s and 80s, Cancer was around the number ten cause of mortality in the United States. However, in 2020 Cancer has now come close to overtaking Heart Disease as the number one cause of mortality in the United States. It is now more likely 1A and 1B for Heart disease and Cancer as the leading cause of mortality in the United States.

One of the biggest issues that has been put forth is this concept of lead time bias….of finding a “cancer” too early where intervention was not needed. By population this issue of finding cancer does not seem to be the case. Because if it were the case, then we should not see the growth of cancer as a leading cause of death in the United States. Therefore, premise at MDIHA is early detection of aberrant cell growth indicators and early prevention therapies that are not necessarily approved FDA treatments.

Women-under-sunshine-Medical-Institute-of-Healthy-Aging-800-x-900-px-.png

At MIHA, we use a combination of non-invasive imaging and innovative blood-based testing to identify patterns linked to:

DNA damage and inflammation

Immune system irregularities

Cancer-associated biomarkers

Disrupted cellular signaling

By detecting these changes early, we can guide patients through customized plans that may help reduce their risk and improve long-term outcomes.

What’s Included in the Aberrant Cell Growth Module

This module offers a comprehensive, proactive approach to early cancer surveillance — even before traditional medical systems would begin testing.

Galleri Cancer Screening MCED annually

Prenuvo or similar MRI whole body technology scan, annually

Tumor Biomarkers with follow up

ALLELICA polygenic risk score

Vitamin C IV quarterly

HD ozone/EBOO quarterly

Thymosin Alpha 1 peptide therapy quarterly injection

Visits – at least 4 to review with Lead Physician results and potential therapy pathways

Older-Woman-Medical-Institute-of-Healthy-Aging-800-x-900-px-.png

This program is designed to give you insight, clarity, and control — even when no symptoms are present.

Benefits include:

Early identification of cancer-associated signals

Personalized prevention strategies

Non-invasive, comprehensive testing tools

Strengthened immune function through targeted therapies

Peace of mind and data-driven decision making

This module is ideal for:

Adults 40+ looking to take charge of long-term cancer risk

Anyone with a family history of cancer

Individuals seeking non-traditional yet scientifically backed prevention tools

Patients with elevated inflammation or immune irregularities

Get in Touch Today

Prevention Starts with Early Detection

You don’t need to wait for a diagnosis to start protecting your future. With the Aberrant Cell Growth Module at MIHA, you’ll receive proactive, precise insights that support longevity — and potentially life-saving decisions — without guesswork.